Key facts
- This page summarizes Wright Don's Form 4 filing for International Stem Cell CORP (ISCO).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Jun 2022, 17:01.
Wright Don - 09 Jun 2022 Form 4 Insider Report for International Stem Cell CORP (ISCO)
- Reporting relationship
- Director
- Issuer ticker
- ISCO
- Reported as of
- 09 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Jun 2022, 17:01:17 UTC
- Prior SEC filing
- 11 Jun 2021
- Next SEC filing
- 16 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Russell Kern, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Wright Don filed Form 4 for International Stem Cell CORP (ISCO) on 10 Jun 2022.
Change
- Previous filing in this sequence was filed on 11 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ISCO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +139,264
- Change %
- Price
- $0.000000
- Shares after
- 139,264
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 139,264
- Exercise price
- $0.4740
- Footnotes
- F1
ISCO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +30,000
- Change %
- Price
- $0.000000
- Shares after
- 30,000
- Date
- 09 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $0.4740
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 09/09/2022.
Footnote F2
Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) 06/09/2023 or (ii) the date of the 2023 Annual Meeting of Stockholders.
SEC remarks
EX-24 attached